-
Product Insights
Braeburn Estates/ Canary Wharf/ Qatari Diar – Belvedere Residential complex – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our Braeburn Estates/ Canary Wharf/ Qatari Diar – Belvedere Residential complex – Greater London report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Buprenorphine PR in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Buprenorphine PR in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Buprenorphine PR in Chronic Low Back Pain (CLBP)...
-
Product Insights
Richborough Estates – Braeburn Way Residential Community – Central Bedfordshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our Richborough Estates - Braeburn Way Residential Community - Central Bedfordshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CAM-2048
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CAM-2048 Drug Details CAM-2048 (buprenorphine) is under development for the treatment of postoperative pain....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – buprenorphine PR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry buprenorphine PR Drug Details Buprenorphine (Buvidal) is a semi-synthetic oripavine derivative, acts as an...
-
Sector Analysis
Opioid Use Disorder – Opportunity Analysis and Forecasts to 2028
Opioids are synthetic or natural agents that stimulate opioid receptors in the brain and nervous system. Opioids are often used to treat patients suffering from pain. When taken in the prescribed quantities, opioids do not generally lead to addiction. Opioid use disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, compulsive use of opioid drugs, and prolonged self-administration of opioid drugs. As the brain adapts to a prolonged opioid use, the patient's tolerance...